Steve N. Slilaty is CEO at Sunshine Biopharma, Inc (SBFM). They have made 2 open-market trades across 1 company since 2012, most recently 2024-03-04.
CIK 0001474684
1 open-market purchase totalling $101K since 2015, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SBFM | 130,000 | $350K |
Shares reported on the most recent Form 4, priced at the 2024-03-05 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.